Obesity

The U.S. Preventive Services Task Force ruled that there is insufficient evidence to recommend for or against screening for food insecurity in primary care.

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost 15.7% of their body weight at 68 weeks, according to topline data from the REDEFINE 2 trial.

Slightly elevated blood glucose within a range of what is generally considered “normal” may be associated with increased risk for heart disease, researchers reported.

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the medication through a new Novo Nordisk direct-to-consumer program.

Obesity prevalence increased among both adults and children across all regions of the world from 1990 to 2021, and more than half of adults are expected to have obesity by 2050, according to two reports published in The Lancet.

Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications, have been found to be associated with new onset acne in women, according to a research letter published in Journal of the American Academy of Dermatology.

The increasingly popular obesity and diabetes drugs known as glucagon-like peptide-1 receptor agonists do not seem to worsen suicidality despite previous concerns, according to recent data published in BMJ.

Adults with a history of depression gained long-term physical health conditions at a rate 30% faster than those without such a history, an analysis of a UK-based nationwide cohort study in PLoS Medicine showed.

Metabolic surgery significantly lowered risk for major adverse liver outcomes vs. nonsurgical management among patients with obesity and compensated cirrhosis from metabolic dysfunction-associated steatohepatitis, according to study data.

Obesity trends have stayed stable in the last couple years, whereas severe obesity has trended downward, a recently published report suggested.